The 13th Early-Stage Life Sciences Technology Conference will showcase about 20 life sciences technologies developed at the universities, research institutions, and hospitals of New England and recently formed New England companies to an audience of angel investors, venture capitalists and corporate investors.

Companies that have presented at our first eleven Early Stage Life Sciences Conferences have raised over $350 million in new investments.